- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有492家主力机构披露2025-06-30报告期持股数据，持仓量总计3.86亿股，占流通A股59.87%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了38%的股票
技术面评分前10的股票
近期的平均成本为47.97元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为47.97元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"47.97","date":1761205870,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2025.10.24","stock":"-1.26","trade":"-0.63","ind":"2.02"},{"date":"2025.10.23","stock":"0.35","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"0.84","trade":"0.70","ind":"-0.62"},{"date":"2025.10.21","stock":"0.55","trade":"0.86","ind":"2.06"},{"date":"2025.10.20","stock":"-0.54","trade":"0.20","ind":"0.98"},{"date":"2025.10.17","stock":"-0.31","trade":"-0.94","ind":"-3.04"},{"date":"2025.10.16","stock":"0.04","trade":"0.75","ind":"-0.25"},{"date":"2025.10.15","stock":"1.35","trade":"1.37","ind":"1.73"},{"date":"2025.10.14","stock":"1.24","trade":"0.32","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.22","trade":"-0.86","ind":"-0.93"},{"date":"2025.10.10","stock":"0.17","trade":"1.31","ind":"-2.70"},{"date":"2025.10.09","stock":"-0.21","trade":"0.26","ind":"1.47"},{"date":"2025.09.30","stock":"-0.63","trade":"0.12","ind":"0.35"},{"date":"2025.09.29","stock":"0.25","trade":"0.13","ind":"2.05"},{"date":"2025.09.26","stock":"0.44","trade":"-0.51","ind":"-1.76"},{"date":"2025.09.25","stock":"-1.52","trade":"-0.70","ind":"0.67"},{"date":"2025.09.24","stock":"2.69","trade":"1.12","ind":"1.80"},{"date":"2025.09.23","stock":"-0.76","trade":"-1.40","ind":"-0.29"},{"date":"2025.09.22","stock":"-1.32","trade":"-0.53","ind":"0.67"},{"date":"2025.09.19","stock":"0.63","trade":"-1.04","ind":"-0.04"},{"date":"2025.09.18","stock":"-0.19","trade":"-1.21","ind":"-1.06"}]
东阿阿胶,深证成指,中药指数
压力支撑
该股压力位为47.99元，支撑位为47.56元。
[{"text":"\u538b\u529b\u4f4d","value":"47.99","date":1761235200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"47.56","date":1761235200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了17%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月24日 20:30
| 机构今日流向(万元) | -2229.81 | 机构5日流向(万元) | -3415.17 |
| 机构10日流向(万元) | -3405.47 | 机构20日流向(万元) | -11798.91 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3326.26万股，其中基金净减仓146家，主力净减仓98家，请投资者中长期谨慎为宜。
截止2025-06-30，共492家主力机构（基金487家，一般法人5家），持仓量总计38555.67万股，占流通A股59.87%
其中，基金持仓与2024-12-31相比：
增仓：78家 ，增持 1533.35万股
减仓：224家 ，减持 3879.35万股
新出现在主力名单中：162家 ，持有2683.21万股
从主力名单中消失：260家 ，原持有3749.67万股
其中，基金持仓与2024-12-31相比：
增仓：78家 ，增持 1533.35万股
减仓：224家 ，减持 3879.35万股
新出现在主力名单中：162家 ，持有2683.21万股
从主力名单中消失：260家 ，原持有3749.67万股
消息面诊股
诊断结果：6.6消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东阿阿胶：10月23日获融资买入2300.85万元
2025-10-24 - 东阿阿胶与上海中医药大学签署战略合作协议
2025-10-23 - 东阿阿胶：10月22日获融资买入2241.48万元
2025-10-23 - 创新药调整到位、信达百亿美金大BD催化，持续看好行
2025-10-22 - A 股中期分红潮持续升温！843 家公司派现超 6
2025-10-22 - 东阿阿胶推动“文化出海”与“产业落地”
2025-10-22 - 东阿阿胶：10月21日持仓该股ETF资金净流入14
2025-10-22 - 东阿阿胶：10月21日获融资买入1535.39万元
2025-10-22 - 中药资源高效利用引关注 研讨会共探科学管理路径
2025-10-21 - 概念动态|东阿阿胶新增“华为概念”
2025-10-21
消息列表
| 利好 | 分红转增 | 10派12.700919元(含税) | 2025-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-21 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-28 |
| 利好 | 分红转增 | 10派12.729896元(含税) | 2025-03-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-18 |
| 一般消息 | 高管变动 | 由于工作变动原因 | 2025-02-25 |
| 利好 | 业绩预告 | 业绩预增 | 2025-01-18 |
| 一般消息 | 高管变动 | 工作变动 | 2024-11-08 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.6行业面打败了91%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2025.10.24","price":"2.02","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.62","value":"0.70"},{"date":"2025.10.21","price":"2.06","value":"0.86"},{"date":"2025.10.20","price":"0.98","value":"0.20"},{"date":"2025.10.17","price":"-3.04","value":"-0.94"},{"date":"2025.10.16","price":"-0.25","value":"0.75"},{"date":"2025.10.15","price":"1.73","value":"1.37"},{"date":"2025.10.14","price":"-2.54","value":"0.32"},{"date":"2025.10.13","price":"-0.93","value":"-0.86"},{"date":"2025.10.10","price":"-2.70","value":"1.31"},{"date":"2025.10.09","price":"1.47","value":"0.26"},{"date":"2025.09.30","price":"0.35","value":"0.12"},{"date":"2025.09.29","price":"2.05","value":"0.13"},{"date":"2025.09.26","price":"-1.76","value":"-0.51"},{"date":"2025.09.25","price":"0.67","value":"-0.70"},{"date":"2025.09.24","price":"1.80","value":"1.12"},{"date":"2025.09.23","price":"-0.29","value":"-1.40"},{"date":"2025.09.22","price":"0.67","value":"-0.53"},{"date":"2025.09.19","price":"-0.04","value":"-1.04"},{"date":"2025.09.18","price":"-1.06","value":"-1.21"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 29.50% | -2.43% | 6.3分 |
| 2 | 特一药业 | 22.60% | 22.32% | 6.2分 |
| 3 | 吉林敖东 | 10.42% | 2.60% | 5.7分 |
| 4 | 方盛制药 | 9.97% | -0.49% | 6.4分 |
| 5 | 信邦制药 | 6.69% | 0.52% | 5.9分 |
| 6 | 粤万年青 | 6.33% | 6.20% | 6.1分 |
| 8 | 金花股份 | 5.73% | 1.07% | 6.0分 |
| 10 | 马应龙 | 4.69% | -1.83% | 5.6分 |
| 12 | 嘉应制药 | 3.32% | 2.03% | 6.2分 |
| 14 | 陇神戎发 | 3.05% | 2.74% | 6.1分 |
| 16 | 盘龙药业 | 2.88% | 5.08% | 6.4分 |
| 18 | 益盛药业 | 2.53% | 2.40% | 5.8分 |
| 20 | 江中药业 | 2.27% | -0.23% | 5.7分 |
| 22 | 佛慈制药 | 1.46% | 0.67% | 5.9分 |
| 24 | 珍宝岛 | 1.37% | 0.85% | 4.8分 |
| 26 | 天士力 | 1.29% | -1.13% | 5.9分 |
| 28 | 华森制药 | 0.71% | 2.63% | 6.8分 |
| 30 | 千金药业 | 0.57% | 1.52% | 6.2分 |
| 32 | 亚宝药业 | 0.30% | -0.15% | 5.4分 |
| 34 | 康恩贝 | 0.00% | 0.22% | 5.9分 |
| 36 | *ST长药 | -0.52% | 0.79% | 4.2分 |
| 38 | 益佰制药 | -0.70% | 1.66% | 5.9分 |
| 40 | 广誉远 | -0.73% | 0.74% | 5.8分 |
| 42 | 上海凯宝 | -0.96% | 1.82% | 5.7分 |
| 44 | ST葫芦娃 | -1.31% | 0.78% | 4.9分 |
| 46 | 沃华医药 | -1.42% | -6.17% | 5.4分 |
| 48 | 华神科技 | -1.74% | 4.21% | 6.1分 |
| 50 | 奇正藏药 | -2.50% | -1.32% | 5.7分 |
| 52 | 同仁堂 | -3.03% | -1.02% | 4.7分 |
| 54 | 济川药业 | -3.14% | -2.22% | 5.2分 |
| 56 | 新天药业 | -3.76% | 1.13% | 5.8分 |
| 58 | 九芝堂 | -5.58% | -0.71% | 5.5分 |
| 60 | 康缘药业 | -5.75% | -5.45% | 4.8分 |
| 62 | 步长制药 | -6.14% | -0.56% | 5.5分 |
| 64 | - | -7.00% | 2.30% | 分 |
| 66 | 振东制药 | -8.58% | -1.84% | 5.4分 |
| 68 | 片仔癀 | -9.00% | -7.96% | 4.9分 |
| 70 | 众生药业 | -11.31% | 2.92% | 6.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/110 ， 12/110。
[{"date":"2025-06-30","value":"7.93","vol":"3.94"},{"date":"2025-03-31","value":"4.04","vol":"2.20"},{"date":"2024-12-31","value":"14.81","vol":"4.81"},{"date":"2024-09-30","value":"11.17","vol":"2.92"},{"date":"2024-06-30","value":"7.05","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.93 | 4.04 | 14.81 | 11.17 | 7.05 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"73.13","vol":"52.43"},{"date":"2025-03-31","value":"73.62","vol":"52.92"},{"date":"2024-12-31","value":"72.42","vol":"52.40"},{"date":"2024-09-30","value":"74.13","vol":"52.75"},{"date":"2024-06-30","value":"73.54","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
73.13 | 73.62 | 72.42 | 74.13 | 73.54 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/110 ， 24/110。
[{"date":"2025-06-30","value":"11.02","vol":"-6.98"},{"date":"2025-03-31","value":"18.24","vol":"-6.63"},{"date":"2024-12-31","value":"25.57","vol":"-6.97"},{"date":"2024-09-30","value":"26.28","vol":"-4.57"},{"date":"2024-06-30","value":"26.80","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
11.02 | 18.24 | 25.57 | 26.28 | 26.80 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"10.74","vol":"2.33"},{"date":"2025-03-31","value":"20.25","vol":"-36.42"},{"date":"2024-12-31","value":"35.29","vol":"-142.71"},{"date":"2024-09-30","value":"47.00","vol":"63.06"},{"date":"2024-06-30","value":"39.03","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
10.74 | 20.25 | 35.29 | 47.00 | 39.03 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 33/110 ， 40/110。
[{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.45","vol":"0.49"},{"date":"2024-09-30","value":"0.33","vol":"0.37"},{"date":"2024-06-30","value":"0.21","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.13 | 0.45 | 0.33 | 0.21 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.89","vol":"1.17"},{"date":"2025-03-31","value":"0.48","vol":"0.60"},{"date":"2024-12-31","value":"1.68","vol":"2.40"},{"date":"2024-09-30","value":"1.22","vol":"1.79"},{"date":"2024-06-30","value":"0.74","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.89 | 0.48 | 1.68 | 1.22 | 0.74 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 3/110 ， 16/110。
[{"date":"2025-06-30","value":"95.30","vol":"20.17"},{"date":"2025-03-31","value":"-17.70","vol":"0.38"},{"date":"2024-12-31","value":"45.83","vol":"15.45"},{"date":"2024-09-30","value":"32.84","vol":"6.15"},{"date":"2024-06-30","value":"21.91","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 95.30 | -17.70 | 45.83 | 32.84 | 21.91 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.28","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.62","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.53","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.28 | - | 0.62 | - | 0.53 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 60/110 ， 62/110。
[{"date":"2025-06-30","value":"4.35","vol":"2.88"},{"date":"2025-03-31","value":"4.38","vol":"2.97"},{"date":"2024-12-31","value":"3.95","vol":"2.86"},{"date":"2024-09-30","value":"3.76","vol":"3.22"},{"date":"2024-06-30","value":"4.65","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.35 | 4.38 | 3.95 | 3.76 | 4.65 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.93","vol":"2.11"},{"date":"2025-03-31","value":"3.97","vol":"2.20"},{"date":"2024-12-31","value":"3.58","vol":"2.09"},{"date":"2024-09-30","value":"3.43","vol":"2.40"},{"date":"2024-06-30","value":"4.18","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.93 | 3.97 | 3.58 | 3.43 | 4.18 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 52/110 ， 51/110。
[{"date":"2025-06-30","value":"19.17","vol":"33.91"},{"date":"2025-03-31","value":"19.17","vol":"33.34"},{"date":"2024-12-31","value":"21.05","vol":"34.08"},{"date":"2024-09-30","value":"21.88","vol":"32.93"},{"date":"2024-06-30","value":"17.95","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
19.17 | 19.17 | 21.05 | 21.88 | 17.95 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.24","vol":"0.74"},{"date":"2025-03-31","value":"0.24","vol":"0.72"},{"date":"2024-12-31","value":"0.27","vol":"0.74"},{"date":"2024-09-30","value":"0.28","vol":"3.16"},{"date":"2024-06-30","value":"0.22","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.24 | 0.24 | 0.27 | 0.28 | 0.22 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 天风证券 | 2025-09-23 | 买入 | |
| 兴业证券 | 2025-09-15 | 增持 | |
| 华泰金融(HK) | 2025-09-09 | 增持 | |
| 华泰证券 | 2025-09-09 | 增持 | 增持 |
| 中信建投证券 | 2025-09-05 | 买入 | |
| 中泰证券 | 2025-09-02 | 买入 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"4.40","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.80","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"18.16","blueLineValue":"2.82","type":"YC"}]